- Home
- IPHA vs GGT Comparison
IPHA vs GGT Comparison
Compare IPHA & GGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- GGT
- Stock Information
- Founded
- IPHA 1999
- GGT 1994
- Country
- IPHA France
- GGT United States
- Employees
- IPHA N/A
- GGT N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- GGT Trusts Except Educational Religious and Charitable
- Sector
- IPHA Health Care
- GGT Finance
- Exchange
- IPHA Nasdaq
- GGT Nasdaq
- Market Cap
- IPHA 160.1M
- GGT 138.5M
- IPO Year
- IPHA 2019
- GGT N/A
- Fundamental
- Price
- IPHA $1.98
- GGT $4.67
- Analyst Decision
- IPHA Strong Buy
- GGT
- Analyst Count
- IPHA 1
- GGT 0
- Target Price
- IPHA $11.50
- GGT N/A
- AVG Volume (30 Days)
- IPHA 16.2K
- GGT 59.7K
- Earning Date
- IPHA 03-27-2025
- GGT 01-01-0001
- Dividend Yield
- IPHA N/A
- GGT 15.56%
- EPS Growth
- IPHA N/A
- GGT N/A
- EPS
- IPHA N/A
- GGT 0.83
- Revenue
- IPHA $20,831,349.00
- GGT N/A
- Revenue This Year
- IPHA $220.44
- GGT N/A
- Revenue Next Year
- IPHA $81.85
- GGT N/A
- P/E Ratio
- IPHA N/A
- GGT $6.90
- Revenue Growth
- IPHA N/A
- GGT N/A
- 52 Week Low
- IPHA $1.29
- GGT $4.32
- 52 Week High
- IPHA $3.51
- GGT $7.00
- Technical
- Relative Strength Index (RSI)
- IPHA 48.63
- GGT 39.62
- Support Level
- IPHA $1.77
- GGT $4.64
- Resistance Level
- IPHA $2.03
- GGT $4.94
- Average True Range (ATR)
- IPHA 0.08
- GGT 0.11
- MACD
- IPHA -0.01
- GGT -0.01
- Stochastic Oscillator
- IPHA 65.63
- GGT 28.95
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About GGT Gabelli Multi-Media Trust Inc. (The)
Gabelli Multimedia Trust Inc is a non-diversified closed-end management investment company. Its investment objective is the long-term growth of capital with income as a secondary objective. The fund invests majority of its assets, under normal market conditions, in common stock and other securities, including convertible securities, preferred stock, options, and warrants of companies in the telecommunications, media, publishing, and entertainment industries.